Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Blood Advances
|
June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Roni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood Advances
|
November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2026
Respiratory Syncytial Virus After CAR T-cell therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort
Maria Isabel Sotelo-Alva, Ofrat Beyar-Katz, Judy Yan, et al.
Blood Advances
|
October 1, 2020
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
David Sermer, Connie Batlevi, M Lia Palomba, et al.
Research Square
|
July 16, 2024
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma
Jae Park, M Lia Palomba, Karlo Perica, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma
Jae H Park, M Lia Palomba, Karlo Perica, et al.
Transplantation and Cellular Therapy
|
April 6, 2026
Outcomes of Salvage Therapy After Early-Line CD19 CAR-T Failure in Large B-Cell Lymphoma
Silvia Escribano Serrat, Andrew Ip, Jaime Sanz, et al.
Cancer
|
September 23, 2020
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma
Pashna N Munshi, David Vesole, Artur Jurczyszyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2022
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Blood Advances
|
June 28, 2023
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Roni Tamari, Michael Scordo, Binni M Kunvarjee, et al.
Blood Advances
|
November 17, 2021
Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja, Michael Scordo, Audrey Mauguen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 24, 2026
Respiratory Syncytial Virus After CAR T-cell therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort
Maria Isabel Sotelo-Alva, Ofrat Beyar-Katz, Judy Yan, et al.
Blood Advances
|
October 1, 2020
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
David Sermer, Connie Batlevi, M Lia Palomba, et al.
Research Square
|
July 16, 2024
Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma
Jae Park, M Lia Palomba, Karlo Perica, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma
Jae H Park, M Lia Palomba, Karlo Perica, et al.
Transplantation and Cellular Therapy
|
April 6, 2026
Outcomes of Salvage Therapy After Early-Line CD19 CAR-T Failure in Large B-Cell Lymphoma
Silvia Escribano Serrat, Andrew Ip, Jaime Sanz, et al.
Cancer
|
September 23, 2020
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma
Pashna N Munshi, David Vesole, Artur Jurczyszyn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2022
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, et al.
Page
of 6